Análisis del impacto de la pandemia del COVID-19 en la atención de las mujeres en situación de aborto en América Latina y el Caribe
PDF (Inglés)
XML (Inglés)

Palabras clave

Embarazo no Planeado
Embarazo en Adolescencia
Embarazo no Deseado
Aborto Espontáneo

Cómo citar

1.
Análisis del impacto de la pandemia del COVID-19 en la atención de las mujeres en situación de aborto en América Latina y el Caribe. Cad. Ibero Am. Direito Sanit. [Internet]. 2024 Mar. 27 [cited 2024 Sep. 20];12(4):14-32. Available from: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/1024

Resumen

Objetivo: comprender la influencia de la pandemia de COVID-19 en aspectos de la calidad de la atención brindada a las mujeres en situación de aborto en los centros centinela de la Red CLAP-MUSA (una red multicéntrica de cooperación internacional con el objetivo de fomentar buenas prácticas en América Latina y el Caribe). Metodología: estudio transversal entre enero/2017 y diciembre/2021 con mujeres de cualquier edad ingresadas para abortos espontáneos o inducidos. Se analizó el número total de casos y la proporción de abortos legales. Las variables dependientes fueron las complicaciones y el uso de anticonceptivos después del aborto. Las variables independientes fueron pandemia de COVID-19, datos clínicos y sociodemográficos. El análisis estadístico se realizó mediante regresión lineal, regresión múltiple de Poisson, pruebas de Cochran-Armitage, chi-cuadrado, Mann-Whitney y Cohen. Resultados: se analizaron datos de 93689 mujeres atendidas en 12 centros centinela de la Red CLAP-MUSA, 64,55% en el período prepandemia (NP) y 35,45% en el período pandemia (PP) (22,73% recibieron atención postaborto y 77,27% aborto legal). No encontramos diferencias en el número de casos durante el período, independientemente del contexto legal. Observamos un aumento significativo en la proporción de abortos legales en contextos liberales y moderados. En NP, el 46,46% de las mujeres se sometieron al aborto con medicamentos, mientras que el 62,18% de las mujeres se sometieron al aborto con medicamentos en PP (h-Cohen 0,32). No encontramos aumento en el número de complicaciones durante el PP. En NP, 79,12% inició anticonceptivos después del aborto, mientras que en PP, 70,39% inició anticonceptivos después del aborto (h-Cohen 0,20). Conclusión: la pandemia de COVID-19 no se asoció con una disminución en el número de casos, una disminución en la proporción de interrupciones legales o un aumento en las complicaciones en los centros centinela de la Red CLAP-MUSA.

Acceptación: 30/04/23|Revisión: 08/11/23|Aprobación: 09/11/23

PDF (Inglés)
XML (Inglés)

Referencias

Organização Pan-Americana da Saúde. OMS afirma que COVID-19 é agora caracterizada como pandemia; 11 mar. 2020. [cited in 04/17/2023]. Available at: https://www.paho.org/pt/news/11-3-2020-who-characterizes-covid-19-pandemic

Sachs JD, Karim SSA, Aknin L, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022 Oct 8;400(10359):1224-1280. Doi https://doi.org/10.1016/S0140-6736(22)01585-9

Cohen MA, Powell AM, Coleman JS, Keller JM, Livingston A, Anderson JR. Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice. Am J Obstet Gynecol. 2020 Sep;223(3):372-378. Doi https://doi.org/10.1016/j.ajog.2020.06.006

Spurlin EE, Han ES, Silver ER, et al. Where Have All the Emergencies Gone? The Impact of the COVID-19 Pandemic on Obstetric and Gynecologic Procedures and Consults at a New York City Hospital. J Minim Invasive Gynecol 2021 Jul; 28(7):1411-1419. Doi https://doi.org/10.1016/j.jmig.2020.11.012

Wenham C, Smith J, Davies SE, Feng H, Grépin KA, Harman S, et al. Women are most affected by pandemics —lessons from past outbreaks. Nature 2020 Jul;583(7815):194–198. Doi https://doi.org/10.1038/d41586-020-02006-z

Islam N, Sharp S J, Chowell G, Shabnam S, Kawachi I, Lacey B et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries BMJ 2020 Jul 15; 370:m2743. Doi https://doi.org/10.1136/bmj.m2743

Limb M. Covid-19: Early stage cancer diagnoses fell by third in first lockdown BMJ 2021 May 7; 373:n1179. Doi https://doi.org/10.1136/bmj.n1179

Gajbhiye RK, Sawant MS, Kuppusamy P, et al. Differential impact of COVID-19 in pregnant women from high-income countries and low- to middle-income countries: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2021 Oct;155(1):48-56. Doi https://doi.org/10.1002/ijgo.13793

Gomez Ponce de Leon R, Baccaro LF, Rubio Schweizer G, et al. Building a network of sentinel centres for the care of women in an abortion situation: advances in Latin America and the Caribbean. BMJ Glob Health. 2022 Oct;7(10):e010059. Doi https://doi.org/10.1136/bmjgh-2022-010059

Fescina R, De Mucio B, Martínez G. Sistema Informático perinatal (SIP): historia clínica perinatal: instrucciones de llenado Y definición de términos. Montevideo: CLAP/SMR, 2011.

World Health Organization. Abortion care guideline. Geneva: World Health Organization 2022 [Cited in 04/17/2023]. Available at: https://www.who.int/publications/i/item/9789240039483

Pattinson R, Say L, Souza JP, et al. WHO maternal death and near-miss classifications. Bull World Health Organ. 2009 Oct;87(10):734. Doi https://doi.org/10.2471/BLT.09.071001

Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ. Lawrence Earlbaum Associates, 1988.

Polis CB, Biddlecom A, Singh S, et al. Impacts of COVID-19 on contraceptive and abortion services in low- and middle-income countries: a scoping review. Sex Reprod Health Matters. 2022 Dec;30(1):2098557. Doi https://doi.org/10.1080/26410397.2022.2098557

Qaderi K, Khodavirdilou R, Kalhor M, et al. Abortion services during the COVID-19 pandemic: a systematic review. Reprod Health. 2023 Apr 13;20(1):61. Doi https://doi.org/10.1186/s12978-023-01582-3

Cohen MA, Powell AM, Coleman JS, et al. Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice. Am J Obstet Gynecol. 2020 Sep;223(3):372-378. Doi https://doi.org/10.1016/j.ajog.2020.06.006

Bayefsky MJ, Bartz D, Watson KL. Abortion during the Covid-19 Pandemic - Ensuring Access to an Essential Health Service. N Engl J Med. 2020 May 7;382(19):e47. Doi https://doi.org/10.1056/NEJMp2008006

IPPF. COVID-19 global impact assessment of IPPF member associations - preliminary analysis and results. IPPF. 2020 [cited in 04/24/2023]. Available at: https://ippf-covid19.org/wpcontent/ uploads/2020/04/Preliminary-results-C-19-MAImpact- survey-April-52.pdf

Chandrasekaran S, Diamond-Smith N, Srinivasan K, Dalvie S. Preparing for an Increased Need for Abortion Access in India during and after COVID-19: Challenges and Strategies. Stud Fam Plann. 2020 Dec;51(4):377-383. Doi https://doi.org/10.1111/sifp.12139

Gichuna S, Hassan R, Sanders T, et al. Access to Healthcare in a time of COVID-19: Sex Workers in Crisis in Nairobi, Kenya. Glob Public Health. 2020 Oct;15(10):1430-1442. Doi https://doi.org/10.1080/17441692.2020.1810298

Vora KS, Saiyed S, Natesan S. Impact of COVID-19 on family planning services in India. Sex Reprod Health Matters. 2020 Dec;28(1):1785378. Doi https://doi.org/10.1080/26410397.2020.1785378

Marquez-Padilla F, Saavedra B. The unintended effects of the COVID-19 pandemic and stay-at-home orders on abortions. J Popul Econ. 2022;35(1):269-305. Doi https://doi.org/10.1007/s00148-021-00874-x

Vora KS, Saiyed S, Natesan S. Impact of COVID-19 on family planning services in India. Sex Reprod Health Matters. 2020 Dec;28(1):1785378. Doi https://doi.org/10.1080/26410397.2020.1785378

VanBenschoten H, Kuganantham H, Larsson EC, et al. Impact of the COVID-19 pandemic on access to and utilisation of services for sexual and reproductive health: a scoping review. BMJ Glob Health. 2022 Oct;7(10):e009594. Doi https://doi.org/10.1136/bmjgh-2022-009594

Endler M, Al-Haidari T, Benedetto C, et al. How the coronavirus disease 2019 pandemic is impacting sexual and reproductive health and rights and response: Results from a global survey of providers, researchers, and policy-makers. Acta Obstet Gynecol Scand. 2021 Apr;100(4):571-578. Doi https://doi.org/10.1111/aogs.14043

Santana DS, Cecatti JG, Parpinelli MA, et al. Severe maternal morbidity due to abortion prospectively identified in a surveillance network in Brazil. Int J Gynaecol Obstet. 2012 Oct;119(1):44-8. Doi https://doi.org/10.1016/j.ijgo.2012.05.025

Upadhyay UD, Desai S, Zlidar V, et al. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015 Jan;125(1):175-183. Doi https://doi.org/10.1097/AOG.0000000000000603

Singh S, Maddow-Zimet I. Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries. BJOG. 2016 Aug;123(9):1489-98. Doi https://doi.org/10.1111/1471-0528.13552

von Hertzen H, Piaggio G, Huong NT, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 2007 Jun 9; 369:1938-46. Doi https://doi.org/10.1016/S0140-6736(07)60914-3

Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynaecol Obstet 2007 Dec; 99 Suppl 2:S172-7. Doi https://doi.org/10.1016/j.ijgo.2007.09.006

Ho PC, Blumenthal PD, Gemzell-Danielsson K, et al. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet 2007 Dec; 99 Suppl 2:S178-81. Doi https://doi.org/10.1016/j.ijgo.2007.09.007

Kaali SG, Szigetvari IA, Bartfai GS. The frequency and management of uterine perforations during first-trimester abortions. Am J Obstet Gynecol 1989 Aug; 161(2):406-8. Doi https://doi.org/10.1016/0002-9378(89)90532-2

Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 2014 Mar-Apr; 20(2):262-78. Doi https://doi.org/10.1093/humupd/dmt045

De La Vega GA, Nemiroff R, Debbs R. Complications of second-trimester dilation and evacuation. Abstracts of Papers and Posters to be Presented at the ACOG 55th Annual Clinical Meeting, May 5-9, 2007, San Diego, CA. Obstet Gynecol. 2007;109 (Suppl 4):21S. Doi https://doi.org/10.1097/01.AOG.0000254431.11590.f9

Allanson B, Jennings B, Jacques A, et al. Infection and fetal loss in the mid-second trimester of pregnancy. Aust N Z J Obstet Gynaecol. 2010;50(03):221–225. Doi https://doi.org/10.1111/j.1479-828X.2010.01148.x

Conde-Agudelo A, Belizán JM, Lammers C. Maternal-perinatal morbidity and mortality associated with adolescent pregnancy in Latin America: Cross-sectional study. Am J Obstet Gynecol. 2005 Feb;192(2):342-9. Doi https://doi.org/10.1016/j.ajog.2004.10.593

Oliveira FC Jr, Surita FG, Pinto E Silva JL, et al. Severe maternal morbidity and maternal near miss in the extremes of reproductive age: results from a national cross- sectional multicenter study. BMC Pregnancy Childbirth. 2014 Feb 20;14:77. Doi https://doi.org/10.1186/1471-2393-14-77

Araújo TVB, Aquino EML, Menezes GMS, et al. Delays in access to care for abortion-related complications: the experience of women in Northeast Brazil. Cad Saude Publica. 2018 Jun 25;34(6):e00168116. Doi https://doi.org/10.1590/0102-311x00168116

Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. Lancet Glob Health. 2020 Sep;8(9):e1152-e1161. Doi https://doi.org/10.1016/S2214-109X(20)30315-6

Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011 Sep;84:230–233. Doi https://doi.org/10.1016/j.contraception.2011.01.013

Lähteenmäki P, Luukkainen T. Return of ovarian function after abortion. Clin Endocrinol. 1978 Feb;8(2):123–132. Doi https://doi.org/10.1111/j.1365-2265.1978.tb02160.x

Tripney J, Kwan I, Bird KS. Postabortion family planning counseling and services for women in low-income countries: a systematic review. Contraception. 2013 Jan;87(1):17-25. Doi https://doi.org/10.1016/j.contraception.2012.07.014

Fondo de Población de las Naciones Unidas. 8.000 millones de vidas infinitas posibilidades. Argumentos a favor de los derechos y libertades. [cited in 04/26/2023]. Available at: https://www.unfpa.org/es/swp2023

Solo J, Billings DL, Aloo-Obunga C, Ominde A, Makumi M. Creating linkages between incomplete abortion treatment and family planning services in Kenya. Stud Fam Plann. 1999 Mar;30(1):17-27. Doi https://doi.org/10.1111/j.1728-4465.1999.00017.x

Mbehero F, Momanyi R, Hesel K. Facilitating Uptake of Post-abortion Contraception for Young People in Kenya. Front Glob Womens Health. 2022 Jan 20;2:733957. Doi https://doi.org/10.3389/fgwh.2021.733957

Kayi EA, Biney AAE, Dodoo ND, Ofori CAE, Dodoo FN. Women's post-abortion contraceptive use: Are predictors the same for immediate and future uptake of contraception? Evidence from Ghana. PLoS One. 2021 Dec 21;16(12):e0261005. Doi https://doi.org/10.1371/journal.pone.0261005

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.

Derechos de autor 2023 Rodolfo Gomez Ponce de Leon, Luiz Francisco Baccaro, Gonzalo Rubio Schweizer, Suzanne Jacob Serruya (Autor)